PH23417A - Improvement in or relating to derivatives of a-21978c cyclic peptide - Google Patents

Improvement in or relating to derivatives of a-21978c cyclic peptide

Info

Publication number
PH23417A
PH23417A PH28905A PH28905A PH23417A PH 23417 A PH23417 A PH 23417A PH 28905 A PH28905 A PH 28905A PH 28905 A PH28905 A PH 28905A PH 23417 A PH23417 A PH 23417A
Authority
PH
Philippines
Prior art keywords
relating
derivatives
improvement
cyclic peptide
peptide
Prior art date
Application number
PH28905A
Other languages
English (en)
Inventor
Manuel Debono
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PH23417A publication Critical patent/PH23417A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/045Actinoplanes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/19Antibiotic
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/27Cyclic peptide or cyclic protein
PH28905A 1982-05-21 1983-05-16 Improvement in or relating to derivatives of a-21978c cyclic peptide PH23417A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/380,499 US4396543A (en) 1982-05-21 1982-05-21 Derivatives of A-21978C cyclic peptides

Publications (1)

Publication Number Publication Date
PH23417A true PH23417A (en) 1989-08-07

Family

ID=23501405

Family Applications (1)

Application Number Title Priority Date Filing Date
PH28905A PH23417A (en) 1982-05-21 1983-05-16 Improvement in or relating to derivatives of a-21978c cyclic peptide

Country Status (14)

Country Link
US (1) US4396543A (ko)
KR (1) KR860002193B1 (ko)
AT (1) AT381104B (ko)
CA (1) CA1216580A (ko)
DD (1) DD210258A5 (ko)
DK (1) DK221283A (ko)
ES (1) ES8407011A1 (ko)
FI (1) FI831747L (ko)
GR (1) GR78850B (ko)
HU (1) HU193528B (ko)
PH (1) PH23417A (ko)
PL (1) PL242097A1 (ko)
PT (1) PT76702B (ko)
RO (1) RO86723B (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4977083A (en) * 1988-04-11 1990-12-11 Eli Lilly And Company Processes for preparing A54145 compounds
DE69739532D1 (de) * 1996-03-08 2009-09-24 Astellas Pharma Inc Prozess für die deacylierung von zyklischen lipopeptiden.
AU784755B2 (en) * 1999-12-15 2006-06-08 Merck Sharp & Dohme Corp. Daptomycin Analogs as antibacterial agents
BR0017028A (pt) * 1999-12-15 2003-01-07 Cubist Pharm Inc Lipopepìdeos como agentes antibacterianos
KR20020063228A (ko) * 1999-12-15 2002-08-01 큐비스트 파마슈티컬즈 인코포레이티드 항균제로서 리포펩티드
PT1390056E (pt) * 2001-04-25 2010-06-09 Wyeth Corp Antibióticos glicopéptidos
WO2010075215A1 (en) * 2008-12-22 2010-07-01 Cubist Pharmaceuticals, Inc. Novel antibacterial agents for the treatment of gram positive infections
US11174288B2 (en) 2016-12-06 2021-11-16 Northeastern University Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3150059A (en) * 1962-12-26 1964-09-22 Lilly Co Eli Penicillin deacylation via actinoplanaceae fermentation
US4050989A (en) * 1974-12-05 1977-09-27 Eisai Co., Ltd. Process of preparing desacyl-pepsidine with bacillus pumilus
US4208403A (en) * 1978-10-16 1980-06-17 Eli Lilly And Company A-21978 Antibiotics and process for their production
US4293485A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of S31794/F-1 nucleus
US4293482A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company A-30912A Nucleus
US4293488A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912B nucleus
US4293483A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912A nucleus
US4293487A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912D nucleus
US4293491A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912H nucleus

Also Published As

Publication number Publication date
KR840005077A (ko) 1984-11-03
DK221283A (da) 1983-11-22
PT76702B (en) 1986-03-27
AT381104B (de) 1986-08-25
DK221283D0 (da) 1983-05-18
HU193528B (en) 1987-10-28
DD210258A5 (de) 1984-06-06
ES522559A0 (es) 1984-09-01
KR860002193B1 (ko) 1986-12-30
FI831747A0 (fi) 1983-05-18
RO86723B (ro) 1985-05-01
ES8407011A1 (es) 1984-09-01
RO86723A (ro) 1985-04-17
ATA178483A (de) 1986-01-15
US4396543A (en) 1983-08-02
PL242097A1 (en) 1984-07-02
FI831747L (fi) 1983-11-22
GR78850B (ko) 1984-10-02
CA1216580A (en) 1987-01-13
PT76702A (en) 1983-06-01

Similar Documents

Publication Publication Date Title
GB2117703B (en) Improvements in or relating to fire-barriers
IL70075A0 (en) Improvements in or relating to 3-aryl-5-pyrazole derivatives
SG55988G (en) Improvements relating to smoking articles
GB2176584B (en) Improvements relating to the treatment of tobacco
EG16042A (en) Improvement in or relating to derivatives of a-21978 c cyclic peptides and their production
GB2155654B (en) Improvements in or relating to eyeguards
IL68700A0 (en) Improvements relating to a-21978c cyclic peptide derivatives and their production
GB8621771D0 (en) Composition to prevent smoking
PH23417A (en) Improvement in or relating to derivatives of a-21978c cyclic peptide
DE3464781D1 (en) Improvements in or relating to engines
DE3360928D1 (en) Improvements in or relating to multimeters
DE3363813D1 (en) Improvements in and relating to substituted tetrahydrona phthalenes
GB2186579B (en) Improvements relating to the radio-labelling of proteins
GB2133056B (en) Improvements in and/or relating to cribwalling
GB2145899B (en) Improvements in or relating to telecines
GB2134577B (en) Improvements in or relating to roadsigns
GB2131895B (en) Improvements in or relating to seals
GB2134902B (en) Improvements in or relating to n-(substituted-methyl)-azetidin-2-ones
CY1490A (en) Improvements in or relating to nasal pharmaceutical compositions
EG16044A (en) Improvements in or relating to derivatives of a-21978 cyclic peptides
GB2122678B (en) Improvements in or relating to releasable fasteners
GB2184338B (en) Improvements relating to smoking articles
GB2184933B (en) Improvements relating to smoking articles
GB2133842B (en) Improvements in or relating to the sealing of casings
EG16043A (en) Improvements in or relating to a-21987 cyclic peptide derivatives and their production